Novo Nordisk A/S: all 1,444 studies

Page 8 of 15. Open to participants first (108), then studies with results posted, then the rest; newest registration first within each.

• Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy PeopleCompletedNCT04059367Phase 1
• A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol LevelsCompletedNCT04058834Phase 1
• Clinical Study to Assess Safety, PK and PD Parameters of CDR132LCompletedNCT04045405Phase 1
• A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical PracticeCompletedNCT04042441
• Long Term Extension Study in Patients With Primary HyperoxaluriaActive, not recruitingNCT04042402Phase 3
• A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 DiabetesCompletedNCT04032197Phase 1
• A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are ChineseCompletedNCT04016974Phase 1
• A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityTerminatedNCT04012255Phase 1
• A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or ObesityCompletedNCT04010786Phase 1
• An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical PracticeCompletedNCT03987802
• A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 DiabetesCompletedNCT03965013Phase 1
• A Study of All-Cause and Cardiovascular Mortality in Type 2 Diabetes Patients Using Basal Insulin Detemir and GlargineCompletedNCT03960814
• A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 DiabetesCompletedNCT03945656Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)CompletedNCT03929679
• A Study to Compare the Uptake Into the Blood of Two Strengths of Somapacitan After Injection Under the Skin in Healthy SubjectsCompletedNCT03905850Phase 1
• Effect of Fiasp® in Type 1 Diabetes TreatmentCompletedNCT03895515
• A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical RoutineCompletedNCT03888157
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)CompletedNCT03876015
• Post-marketing Surveillance (Use Result Surveillance) With Refixia®CompletedNCT03875547
• A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in AlgeriaWithdrawnNCT03862690
• A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With ObesityCompletedNCT03842202Phase 1
• A Research Study, Looking at How Xultophy® Works in People With Type 2 Diabetes in Local Clinical Practice in United Arab EmiratesCompletedNCT03823339
• A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease PatientsCompletedNCT03815695Phase 1
• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 DiabetesActive, not recruitingNCT03811561Phase 3
• An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 DiabetesCompletedNCT03811288
• A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in PortugalCompletedNCT03797885
• A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or TogetherCompletedNCT03789578Phase 1
• A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With ObesityCompletedNCT03787225Phase 1
• An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 DiabetesCompletedNCT03786406
• A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Saudi ArabiaCompletedNCT03785522
• Study of Safety and Tolerability of DCR HBVSCompletedNCT03772249Phase 1
• A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a WeekCompletedNCT03766854Phase 1
• RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in JapanCompletedNCT03745157
• A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)CompletedNCT03741881
• A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney ProblemsCompletedNCT03723785Phase 1
• A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a WeekCompletedNCT03723772Phase 1
• A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes MellitusCompletedNCT03723759Phase 1
• A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or ObeseCompletedNCT03707990Phase 1
• A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes MellitusCompletedNCT03674866
• Validation of a Questionnaire That Identifies the Reasons for Non-adherence to Existing Growth Hormone TherapyCompletedNCT03672617
• Research Study of a New Medicine (NNC9204-1706) in People With Overweight or ObesityCompletedNCT03661879Phase 1
• A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With HemophiliaCompletedNCT03660774
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)CompletedNCT03648281
• Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy MenCompletedNCT03638778Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)CompletedNCT03631186
• First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.CompletedNCT03617081Phase 1
• A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector)CompletedNCT03611322Phase 1
• A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or ObeseCompletedNCT03600480Phase 1
• A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection ToolsCompletedNCT03598621Phase 1
• Awareness, Care & Treatment In Obesity Management - An International ObservationCompletedNCT03584191
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or ObeseCompletedNCT03574584Phase 1
• A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.CompletedNCT03560336
• A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or ObesityCompletedNCT03479892Phase 1
• In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care DatabaseCompletedNCT03479762
• A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy SubjectsCompletedNCT03466567Phase 1
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical PracticeCompletedNCT03457012
• Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® DeviceCompletedNCT03450863
• First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.CompletedNCT03444467Phase 1
• Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)CompletedNCT03435627
• Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)CompletedNCT03430154
• A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in KoreaCompletedNCT03416855
• A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT03407599Phase 1
• Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary HyperoxaluriaCompletedNCT03392896Phase 1
• A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03374774
• A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the LiverCompletedNCT03357380Phase 1
• Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or ObesityCompletedNCT03308721Phase 1
• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese SubjectsCompletedNCT03292185Phase 1
• A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese SubjectsCompletedNCT03288740Phase 1
• Awareness, Care and Treatment in Obesity ManagementCompletedNCT03235102
• Awareness, Care & Treatment in Obesity Management (ACTION) StudyCompletedNCT03223493
• Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.CompletedNCT03220425Phase 3
• A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 DiabetesCompletedNCT03215498Phase 1
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function.CompletedNCT03212131Phase 1
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal FunctionCompletedNCT03186495Phase 1
• Study Investigating Novoeight®/NovoEight® (Turoctocog Alfa) in Mexican Haemophilia A PatientsCompletedNCT03179748
• Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male SubjectsCompletedNCT03144271Phase 1
• Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With ObesityCompletedNCT03095807Phase 1
• A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia BCompletedNCT03075670Phase 1
• Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in IndiaWithdrawnNCT03070704
• First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or ObesityCompletedNCT03015207Phase 1
• A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy SubjectsCompletedNCT03010475Phase 1
• Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia ACompletedNCT02994407Phase 1
• In-market Utilisation of Liraglutide Used for Weight Management in EuropeCompletedNCT02967757
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 DiabetesCompletedNCT02964104Phase 1
• A Trial Investigating the Absorption, Metabolism and Excretion of Somapacitan After Single Dosing in Healthy Male SubjectsCompletedNCT02962440Phase 1
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or OverweightCompletedNCT02958085Phase 1
• Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia ACompletedNCT02941354Phase 1
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.CompletedNCT02941042Phase 1
• A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes MellitusCompletedNCT02938572Phase 1
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 2 Diabetes MellitusCompletedNCT02933853Phase 1
• A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia ACompletedNCT02920398Phase 1
• A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.CompletedNCT02920385Phase 1
• A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects.CompletedNCT02911870Phase 1
• Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.CompletedNCT02877355Phase 1
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With ObesityCompletedNCT02870231Phase 1
• A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal FemalesCompletedNCT02845219Phase 1
• A Trial Investigating the Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart in Healthy Chinese SubjectsCompletedNCT02844790Phase 1
• A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With ObesityCompletedNCT02835235Phase 1
• Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®CompletedNCT02821052
• A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)TerminatedNCT02795325Phase 1

← Novo Nordisk A/S overview and focus areas